Volume 118, Issue 2 pp. 438-441

Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?

Massimo Breccia

Massimo Breccia

Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome,

Search for more papers by this author
Maria C. Petti

Maria C. Petti

Ematologia-Istituto Regina Elena, and

Search for more papers by this author
Emanuela Ottaviani

Emanuela Ottaviani

Istituto Ematologia ‘Seragnoli’, Ospedale S. Orsola, Bologna, Italy

Search for more papers by this author
Marco Mancini

Marco Mancini

Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome,

Search for more papers by this author
Gianna Maria D'Elia

Gianna Maria D'Elia

Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome,

Search for more papers by this author
Sergio Mecarocci

Sergio Mecarocci

Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome,

Search for more papers by this author
Giuliana Alimena

Giuliana Alimena

Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome,

Search for more papers by this author
First published: 25 July 2002
Citations: 22
Dr Massimo Breccia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Universita ‘La Sapienza’, Via Benevento 6, Rome, Italy. E-mail: [email protected]

Abstract

Summary. Two cases of acute myeloid leukaemia (AML) with CD2 and CD7 expression associated with diabetes insipidus (DI) as the initial symptom are presented. Both patients had t(3;3)(q21;q26) associated with monosomy 7 and EVI-1 overexpression. No neurohypophysis infiltration was evident. One patient died during induction chemotherapy, the other did not respond to therapy and died with persistent DI. Our findings further support the existence of a distinct AML entity characterized by the presence of DI, abnormalities of chromosome 3q, dysmegakaryopoiesis and poor outcome, and provide evidence of EVI-1 gene involvement. The possible role of chromosome 3q26 abnormalities in determining this peculiar clinical–biological association is emphasized.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.